Daewon Pharmaceutical Co., Ltd. (KRX:003220)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,840
-30 (-0.28%)
Apr 29, 2026, 11:24 AM KST
-21.22%
Market Cap 232.98B
Revenue (ttm) 605.43B
Net Income (ttm) -1.38B
Shares Out 21.43M
EPS (ttm) -87.38
PE Ratio n/a
Forward PE 16.30
Dividend 250.00 (2.29%)
Ex-Dividend Date Dec 29, 2025
Volume 11,115
Average Volume 30,533
Open 10,830
Previous Close 10,870
Day's Range 10,730 - 10,950
52-Week Range 9,670 - 14,700
Beta 0.26
RSI 56.51
Earnings Date May 15, 2026

About Daewon Pharmaceutical

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company’s principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a t... [Read more]

Sector Healthcare
Founded 1958
Employees 1,283
Stock Exchange Korea Stock Exchange
Ticker Symbol 003220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.